Resultados de la búsqueda 721-730 of 2058 for decrease defined generation

  1. Ensayos clínicos - Neurología

    ... decline (e.g., Mueller et al, 2018). We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant ...

  2. Ensayos clínicos - Neurología

    ... reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study will help us to develop better ways to provide care and advice, develop better treatments to minimize long-term side effects, and improve the ...

  4. Terapia con testosterona: beneficios y riesgos posibles a medida que envejece - Mayo Clinic

    ¿Qué es la testosterona? · Densidad ósea · Distribución de la grasa · Fuerza y masa muscular · Vello facial y corporal · Producción de glóbulos rojos · Deseo sexual ...

  5. Ensayos clínicos - Neurología

    This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...

  6. Medicina cardiovascular - Ensayos clínicos

    ... reduction of paroxysmal atrial fibrillation (AF) burden. A Study of Lung Ultrasound to Assess Extravascular Lung Water. Rochester, Minn. The purpose of this ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... define the patient experience of men with advanced prostate cancer and identify unmet needs in their treatment; and to identify clinical and molecular ...

  8. Neurología - Ensayos clínicos

    ... decline (e.g., Mueller et al, 2018). We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant ...

  9. Ensayos clínicos - Neurología

    ... decline (e.g., Mueller et al, 2018). We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant ...

  10. Oncología (médica) - Ensayos clínicos

    Complete response is at 3 or 6 months defined as absence of any UTUC in the renal pelvis. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non ...